Search

Your search keyword '"Duvoux, Christophe"' showing total 250 results

Search Constraints

Start Over You searched for: Author "Duvoux, Christophe" Remove constraint Author: "Duvoux, Christophe" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
250 results on '"Duvoux, Christophe"'

Search Results

1. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study

2. Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study

3. The liver in sickle cell disease

4. Artificial Intelligence and liver: Opportunities and barriers

7. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

8. Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study

10. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

12. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)

13. Covid-19 in liver transplant recipients: the French SOT COVID registry

14. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients

16. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score

17. Long term results of liver transplantation for alpha-1 antitrypsin deficiency

19. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study

20. Selective internal radiation therapy for unresectable HCC: The SIRT downstaging study.

21. Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis

22. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study

23. Autoimmune hepatitis recurrence after liver transplantation: “Les jeux sont faits”.

24. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry

25. Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry

26. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma

27. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series

28. Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort

30. Direct-acting antiviral agent–based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

32. Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant

33. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC

35. Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence – The ANRS CUPILT study

36. Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

38. Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension Study

39. Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study.

40. Artificial Intelligence and liver: Opportunities and barriers.

41. Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation

47. Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: A French experience on 250 patients over 15 years (the Orfèvre study)

48. Long term results of liver transplantation for Wilson’s disease: Experience in France

49. Survival of children after liver transplantation for hepatocellular carcinoma

50. Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH Study.

Catalog

Books, media, physical & digital resources